Headline:

Huang Calls AI Fears an Engineering Problem, Not a Regulation Problem

Summary:

Key Points

1. Nvidia's Jensen Huang publicly pushed back this week against Anthropic CEO Dario Amodei's call to slow AI development.
2. Huang told Dreamforce that safety is an engineering problem and labs should withhold products they doubt.
3. Nvidia sells the chips powering the AI race and expects to double chip sales next year.

The latest:

Safety in artificial intelligence is an engineering problem rather than a matter for new laws, Nvidia CEO Jensen Huang said at Salesforce’s Dreamforce conference, according to The Wall Street Journal. His remarks came days after Anthropic CEO Dario Amodei published an essay urging the industry to collectively slow development of advanced AI models. Huang repeated the argument across several venues during the week.

Details:

• The remarks: Huang told the Dreamforce audience that safety is paramount and in many ways job one, but framed it as an engineering challenge. If a company is not confident in a product’s functionality, capability or safety, it should not release it, he said, according to the Journal.
• Amodei’s position: The Anthropic chief executive, 43, called in a lengthy essay a weekend earlier for the industry to collectively slow work on advanced models. The Journal noted he has not paused Anthropic’s own development, and that his warnings fed a wider national debate over AI risk.
• The commercial stake: Nvidia is the world’s most valuable company and its chips sit at the center of AI development. Huang told reporters in Scotland he expects Nvidia to sell twice as many chips next year as this year because of AI demand, the Journal reported.
• The Trump angle: At an All-In Podcast event on Monday, Huang put President Trump on speakerphone for the audience. Trump called AI concerns a hoax and Huang agreed, the Journal reported, with the two saying they would not let the other side prevail.
• Tied together: Anthropic depends on Nvidia’s chips, while Nvidia is in talks to invest in Anthropic through its upcoming initial public offering, according to a Reuters report cited by the Journal. Nvidia is already an investor in several AI companies, including OpenAI.
• The open-model fight: In late July, after strong open models emerged from China, Huang rallied industry support for open AI models through a public letter. He posted on X, in his first post on the platform, that the world needs both frontier closed models and frontier open models.
• Anthropic’s counter: Amodei has warned Congress about bad actors using open-source AI and issued a letter rejecting claims he wanted to ban open models. His latest essay repeated calls to crack down on unauthorized distillation in countries such as China and on chip smuggling, the Journal said.
• The generational read: Author Antonio Garcia Martinez argued on social media that AI doomerism splits by age, with younger lab staff treating it as the end of the world while older figures such as Huang and Marc Andreessen say chill out. Jacob Coxon, the former OpenAI and Anthropic researcher whose resignation this month renewed scrutiny, is 27.
• Huang on the rhetoric: At Monday’s event Huang called predictions of catastrophe irresponsible and said such companies ought to be built the way firms used to be built, in silence. He also cautioned at King Charles III’s AI summit in Scotland against conflating the technology itself with a specific AI product.

Between the lines:

The Journal notes the self-interest in Huang’s position: the company selling picks and shovels has little reason to call the gold rush dangerous. It also frames a structural worry — if Anthropic and OpenAI consolidate into a duopoly resembling Apple and Google in smartphones, Nvidia’s leverage shrinks. A crowded field of buyers, and open models that widen it, serve Nvidia’s pricing power.

What’s next

Watch Anthropic’s planned IPO and whether Nvidia’s investment talks convert into a stake, plus any move in Washington toward AI legislation or tighter export and chip-smuggling enforcement aimed at China.